Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9B4Z

E. coli 70S ribosome complex (N1-methylated 16S A1408 + arbekacin)

This is a non-PDB format compatible entry.
Summary for 9B4Z
Entry DOI10.2210/pdb9b4z/pdb
EMDB information44192
Descriptor16S ribosomal RNA, 30S ribosomal protein S10, 30S ribosomal protein S11, ... (58 entities in total)
Functional Keywordsaminoglycoside, a1408, resistance, ribosome
Biological sourceEscherichia coli
More
Total number of polymer chains56
Total formula weight2249966.58
Authors
Mattingly, J.M.,Dey, D.,Zelinskaya, N.,Dunham, C.M.,Conn, G.L. (deposition date: 2024-03-21, release date: 2025-08-27, Last modification date: 2025-09-10)
Primary citationDey, D.,Mattingly, J.M.,Zelinskaya, N.,Dunham, C.M.,Conn, G.L.
Basis for selective drug evasion of an aminoglycoside-resistance ribosomal RNA modification.
Nat Commun, 16:7992-7992, 2025
Cited by
PubMed Abstract: Aminoglycosides disrupt the fidelity of bacterial protein synthesis, but their potent antibacterial activity is threatened by multiple resistance mechanisms, including methylation of their ribosomal RNA (rRNA) binding site. However, the impact of one such resistance-conferring methylation on N1 of helix 44 nucleotide A1408 (mA1408) is highly variable with some aminoglycosides retaining significant potency. Here, we examine bacterial susceptibility to diverse aminoglycosides, determine high-resolution electron cryomicroscopy structures of mA1408-modified 70S ribosome-aminoglycoside complexes, and perform molecular dynamics simulations to decipher the key determinants of such "resistance evasion." Collectively, these analyses reveal how some aminoglycosides adapt their conformation to accommodate mA1408, including the roles of specific ring substituents, balancing ligand strain and maintaining favorable interactions, as well as interactions made by additional functional groups that compensate for those disrupted by the modification. This work provides design principles that can guide future rational development of aminoglycosides refractory to resistance conferred by rRNA modifications.
PubMed: 40866347
DOI: 10.1038/s41467-025-63278-5
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.2 Å)
Structure validation

242842

PDB entries from 2025-10-08

PDB statisticsPDBj update infoContact PDBjnumon